Ozkizilkaya, H.I.; Vinocha, A.; Dono, A.; Ogunbona, O.B.; Toruner, G.A.; Aung, P.P.; Kamiya Matsuoka, C.; Esquenazi, Y.; DeMonte, F.; Ballester, L.Y.
MTAP and p16 IHC as Markers for CDKN2A/B Loss in Meningiomas. Cancers 2024, 16, 3299.
https://doi.org/10.3390/cancers16193299
AMA Style
Ozkizilkaya HI, Vinocha A, Dono A, Ogunbona OB, Toruner GA, Aung PP, Kamiya Matsuoka C, Esquenazi Y, DeMonte F, Ballester LY.
MTAP and p16 IHC as Markers for CDKN2A/B Loss in Meningiomas. Cancers. 2024; 16(19):3299.
https://doi.org/10.3390/cancers16193299
Chicago/Turabian Style
Ozkizilkaya, Hanim I., Anjali Vinocha, Antonio Dono, Oluwaseun Basit Ogunbona, Gokce A. Toruner, Phyu P. Aung, Carlos Kamiya Matsuoka, Yoshua Esquenazi, Franco DeMonte, and Leomar Y. Ballester.
2024. "MTAP and p16 IHC as Markers for CDKN2A/B Loss in Meningiomas" Cancers 16, no. 19: 3299.
https://doi.org/10.3390/cancers16193299
APA Style
Ozkizilkaya, H. I., Vinocha, A., Dono, A., Ogunbona, O. B., Toruner, G. A., Aung, P. P., Kamiya Matsuoka, C., Esquenazi, Y., DeMonte, F., & Ballester, L. Y.
(2024). MTAP and p16 IHC as Markers for CDKN2A/B Loss in Meningiomas. Cancers, 16(19), 3299.
https://doi.org/10.3390/cancers16193299